Shelton Capital Management’s Charles River Laboratories CRL Stock Holding History

Shelton Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,774	Closed	-$804K	–	836
2021 Q1	$804K	Hold	2,774	–	–	0.03%	307
2020 Q4	$693K	Sell	2,774 -71	-2%	-$16.9K	0.03%	299
2020 Q3	$644K	Hold	2,845	–	–	0.03%	397
2020 Q2	$496K	Sell	2,845 -148	-5%	-$23.6K	0.03%	326
2020 Q1	$378K	Sell	2,993 -152	-5%	-$22.8K	0.03%	345
2019 Q4	$480K	Sell	3,145 -127	-4%	-$17.6K	0.03%	359
2019 Q3	$433K	Hold	3,272	–	–	0.03%	391
2019 Q2	$464K	Buy	3,272 +2,772	+554%	+$376K	0.03%	365
2019 Q1	$3.44K	Sell	500 -2,942	-85%	-$387K	0.01%	686
2018 Q4	$390K	Hold	3,442	–	–	0.03%	377
2018 Q3	$463K	Hold	3,442	–	–	0.03%	382
2018 Q2	$386K	Hold	3,442	–	–	0.02%	444
2018 Q1	$367K	Hold	3,442	–	–	0.02%	463
2017 Q4	$377K	Hold	3,442	–	–	0.02%	477
2017 Q3	$372K	Hold	3,442	–	–	0.03%	473
2017 Q2	$348K	Hold	3,442	–	–	0.02%	498
2017 Q1	$310K	Hold	3,442	–	–	0.02%	559
2016 Q4	$262K	Sell	3,442 -1,370	-28%	-$104K	0.02%	689
2016 Q3	$401K	Hold	4,812	–	–	0.03%	459
2016 Q2	$397K	Hold	4,812	–	–	0.04%	452
2016 Q1	$365K	Hold	4,812	–	–	0.03%	473
2015 Q4	$387K	Hold	4,812	–	–	0.04%	435
2015 Q3	$306K	Hold	4,812	–	–	0.03%	524
2015 Q2	$338K	Hold	4,812	–	–	0.04%	528
2015 Q1	$382K	Hold	4,812	–	–	0.04%	491
2014 Q4	$306K	Sell	4,812 -700	-13%	-$43.9K	0.04%	566
2014 Q3	$329K	Hold	5,512	–	–	0.04%	508
2014 Q2	$295K	Hold	5,512	–	–	0.04%	570
2014 Q1	$333K	Hold	5,512	–	–	0.05%	476
2013 Q4	$292K	Hold	5,512	–	–	0.04%	523
2013 Q3	$255K	Hold	5,512	–	–	0.04%	530
2013 Q2	$226K	Buy	+5,512	New	+$236K	0.04%	553

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Shelton Capital Management's CRL Position: Q2 2021 in Review

Shelton Capital Management sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 2,774 shares — an estimated $804K sold.

Shelton Capital Management first reported a position in CRL in Q2 2013 and held it in 32 quarters. The position peaked at $804K in Q1 2021. 639 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

Shelton Capital Management reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
Shelton Capital Management sold 2,774 Charles River Laboratories shares in Q2 2021, an estimated $804K.
Shelton Capital Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 32 quarters.
Shelton Capital Management's Charles River Laboratories position peaked at $804K in Q1 2021.
639 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Shelton Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.